Acquired Treatment Resistance in a Patient with Metastatic PD-L1-Positive Breast Cancer and Germline BRCA1 Mutation

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer associated with higher rates of relapse and mortality compared to other subtypes. Chemotherapy has been a mainstream treatment approach for TNBC due to the lack of therapeutic targets. Recent advances have led to the intr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumeta, Toko, Yamaguchi, Kei, Hayami, Ryosuke, Arai, Kazumori, Tsuneizumi, Michiko, Matsunuma, Ryoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359695/
https://www.ncbi.nlm.nih.gov/pubmed/37485016
http://dx.doi.org/10.1159/000530131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359695/
https://www.ncbi.nlm.nih.gov/pubmed/37485016
http://dx.doi.org/10.1159/000530131

Ejemplares similares